FDA Grants Traditional Approval to Tarlatamab-dlle for Extensive Stage Small Cell Lung Cancer By Ogkologos - January 22, 2026 46 0 Facebook Twitter Google+ Pinterest WhatsApp Evidence for efficacy is based on the results from the DeLLphi-304 study Source RELATED ARTICLESMORE FROM AUTHOR AI-Supported Mammography Screening Shows Favourable Outcomes Compared with Standard Double Reading ESMO Welcomes European Parliament Resolution Marking World Cancer Day FDA Approves Daratumumab and Hyaluronidase-fihj with Bortezomib, Lenalidomide, and Dexamethasone for Patients with Newly Diagnosed Multiple Myeloma MOST POPULAR For Early-Stage Lung Cancer, Nivolumab and Chemo before Surgery Proves Effective May 20, 2022 17 Old Fashioned Ways to Get Rid of Ants in Your... March 27, 2019 Embedding research integrity at the core of our science July 28, 2021 Jiffy Lube Surprises Volunteer Who Drives Cancer Patients To Treatment With... December 11, 2019 Load more HOT NEWS A new approach to cancer immunotherapy Researchers Turn On PTEN Tumor-Suppressor Protein in Cancer Cells Young Breast Cancer Survivors Without a Germline Pathogenic Variant Have a... Less Frequent Mammographic Surveillance Non-inferior Compared with Annual Mammograms After Diagnosis...
